Reliable pharmaceutical supply 2024

Reliable pharmaceutical supply UK/US/Europe: Reliable commercial drug sourcing and supply for clinical research, with a truly global approach. ClientPharma is perfectly equipped to ensure fast, accurate and reliable pharmaceutical supply. With unparalleled service and unmatched access, ClientPharma sources and supplies commercial drug product for global clinical trials. From provision of clinical research samples, to bulk supplies for your pivotal trials, we have the network and know-how to provide strategic sourcing solutions at every stage of clinical research. See more info on top global clinical trial supply companies.

ClientPharma is licensed and follows regulatory directives and guidelines, complying with Good Distribution Practice (GDP) for Medicines for Human Use, 2013/C 343/01. Our Quality Department is responsible for vigorously maintaining the quality and integrity of your products through our comprehensive Quality Management System. Continuous focus and commitment to quality assures compliance across the board — for the client, for the regulatory agencies, and most importantly, for the patient.

From sample requests to global bulk supply procurement and distribution, we work as an extension of your team to guide you through the appropriate steps to mitigate risks. From start-to-finish, we utilize our extensive expertise and breadth of knowledge to navigate: Market Intelligence; Supply Chain Planning; Risk Management; Sourcing; Waste Management; Storage & Distribution; Documentation Management; Returns, Reconciliation & Destruction Services.

On May 20th, we celebrate International Clinical Trials Day 2023. It is a day to reflect on the ground-breaking work and significant contributions of clinical trials in advancing medical research, improving patient care and transforming lives worldwide. Our heartfelt gratitude goes out to the patients participating in clinical trials and we extend our appreciation to all those that make the clinical trials possible; the researchers, physicians, nurses, and healthcare professionals, with their unwavering dedication to bring new and innovative treatments to those in need. Together we can shape the future of medicine and make a lasting impact on the lives of millions. Happy International Clinical Trials Day! Find more details on https://www.clientpharma.com/.

Under this partnership, clients will now enjoy an expanded reach by leveraging ClientPharma’s global sourcing, procurement and distribution logistics while also having the ability to utilize the RxStudy CardTM, TrialCard’s virtual inventory supply solution that has been augmented to place physical inventories of medication at sites for protocol designs that require immediate dosing. This will cut supply costs by 50% and reduce clinical supply teams’ efforts by 80%. TrialCard Incorporated is a full-service life sciences commercialization partner that provides comprehensive solutions that span the entire biopharmaceutical value chain. In addition to a foundation of fully integrated, digitally enabled patient support services, its broader offerings include everything from late-stage clinical trial management to post-marketing HCP engagement services and proprietary data-as-a-service payer intelligence and insights. Founded in 2000, TrialCard provides commercialization needs for more than 160 life science customers and has connected over 35 million patients with more than $18 billion in branded drug savings to date. The company is headquartered in Morrisville, North Carolina.

When volatility of the market is coupled with the increasing complexity of the manufacturing process it creates a new drive for manufacturing solutions. Recently, pharmaceutical companies have begun to move away from conventional forms of manufacturing to use more flexible and modular models. These models are said to increase capacity, reduce costs and decrease development time in clinical trials. Flexibility in the manufacturing process also means that capacity for a drug can be scaled down to accommodate variability and volatility in the market. This can in turn reduce inaccurate estimates when supplying new medicines. Using this model, clients can then increase and decrease orders as and when they need to rather than bulk buying and ending up with surplus. In addition to these new approaches, disposable equipment has also become a major solution. Components such as hoses and bags are swapped over during the process, meaning that production never needs to stop. Although these approaches are often seen as more costly than traditional methods in the first instance, their benefits often out way their risks by creating a more flexible process.